Mandeg, Michell T.

HRN: 11-48-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2022
CEFUROXIME 1.5GM (VIAL)
07/30/2022
07/31/2022
IVT
1.5gm
Q8H X 3 Doses
S/P NSVD; UTI
Waiting Final Action 
07/31/2022
CEFUROXIME 500MG (TAB)
07/31/2022
08/07/2022
ORAL
500mg/tab
BID
S/P NSVD; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: